(PBGD) is, reportedly, encoded by 2 dis-tinct messenger RNAs (mRNAs) transcrib-ing from a single gene. The ubiquitous form of the PBGD gene product is often used as an endogenous reference in gene expression studies because it is pseudo-gene free and has minimal transcriptional variability among tissues. A distinct ery-throid-specific gene product has also been described because of the alternate splicing of the gene. Here is reported the existence of an additional erythroid-spe-cific isoform of PBGD mRNA in primary cells. (Blood. 2001;97:815-817) © 2001 by The American Society of Hematolog
AbstractAcute intermittent porphyria (AIP) is a neuropathic disease caused by a dominant inherited d...
SIGLECNRS T Bordereau / INIST-CNRS - Institut de l'Information Scientifique et TechniqueFRFranc
AbstractTerminal erythroid differentiation in mammals is the process whereby nucleated precursor cel...
textabstractWe have studied the erythroid-specific promoter of the human gene coding for Porphobilin...
Porphobilinogen deaminase, the third enzyme of the haem biosynthesis pathway catalyses the stepwise ...
The regional gene assignments for human porphobilinogen deaminase (PBGD; EC 4.3.1.8) and esterase A4...
scription and splicing of the human porpho-bilinogen deaminase gene result either in tissue-specific...
Objective. In the course of developing assays for the molecular prediction of biological age, we ser...
Erythroid terminal differentiation (ETD) describes the latest stages of erythrocyte differentiation ...
Acute intermittent porphyria is an inborn error of haem synthesis which is transmitted as a dominant...
Porphyria cutanea tarda (POT) results from a metabolic block in heme synthesis at the level of uropo...
Summary: To study the existence of different mutations in acute intermittent porphyria, erythrocyte ...
Objective: In the course of developing assays for the molecular prediction of biological age, we ser...
Genetic variants in promoters and alternative-splicing lesions require to be experimentally tested i...
SummaryAcute intermittent porphyria (AIP) is the major autoso-mal dominant form of acute hepatic por...
AbstractAcute intermittent porphyria (AIP) is a neuropathic disease caused by a dominant inherited d...
SIGLECNRS T Bordereau / INIST-CNRS - Institut de l'Information Scientifique et TechniqueFRFranc
AbstractTerminal erythroid differentiation in mammals is the process whereby nucleated precursor cel...
textabstractWe have studied the erythroid-specific promoter of the human gene coding for Porphobilin...
Porphobilinogen deaminase, the third enzyme of the haem biosynthesis pathway catalyses the stepwise ...
The regional gene assignments for human porphobilinogen deaminase (PBGD; EC 4.3.1.8) and esterase A4...
scription and splicing of the human porpho-bilinogen deaminase gene result either in tissue-specific...
Objective. In the course of developing assays for the molecular prediction of biological age, we ser...
Erythroid terminal differentiation (ETD) describes the latest stages of erythrocyte differentiation ...
Acute intermittent porphyria is an inborn error of haem synthesis which is transmitted as a dominant...
Porphyria cutanea tarda (POT) results from a metabolic block in heme synthesis at the level of uropo...
Summary: To study the existence of different mutations in acute intermittent porphyria, erythrocyte ...
Objective: In the course of developing assays for the molecular prediction of biological age, we ser...
Genetic variants in promoters and alternative-splicing lesions require to be experimentally tested i...
SummaryAcute intermittent porphyria (AIP) is the major autoso-mal dominant form of acute hepatic por...
AbstractAcute intermittent porphyria (AIP) is a neuropathic disease caused by a dominant inherited d...
SIGLECNRS T Bordereau / INIST-CNRS - Institut de l'Information Scientifique et TechniqueFRFranc
AbstractTerminal erythroid differentiation in mammals is the process whereby nucleated precursor cel...